OMERS Administration Corp’s Abeona Therapeutics ABEO Stock Holding History

OMERS Administration Corp’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,400	Closed	-$70.8K	–	1033
2025 Q3	$70.8K	Buy	+13,400	New	+$85K	﹤0.01%	1076
2025 Q2	–	Sell	-72,200	Closed	-$344K	–	864
2025 Q1	$344K	Buy	72,200 +7,155	+11%	+$38.9K	﹤0.01%	831
2024 Q4	$362K	Buy	+65,045	New	+$400K	﹤0.01%	778
2024 Q2	–	Sell	-12,400	Closed	-$89.9K	–	1029
2024 Q1	$89.9K	Buy	+12,400	New	+$78.6K	﹤0.01%	331

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

OMERS Administration Corp's ABEO Position: Q4 2025 in Review

OMERS Administration Corp sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 13,400 shares — an estimated $70.8K sold.

OMERS Administration Corp first reported a position in ABEO in Q1 2024 and held it in 4 quarters. The position peaked at $362K in Q4 2024. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

OMERS Administration Corp reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
OMERS Administration Corp sold 13,400 Abeona Therapeutics shares in Q4 2025, an estimated $70.8K.
OMERS Administration Corp first reported a position in Abeona Therapeutics in Q1 2024 and held it in 4 quarters.
OMERS Administration Corp's Abeona Therapeutics position peaked at $362K in Q4 2024.
104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.